Health-related quality of life effects of enzalutamide in patients with metastatic castration-resistant prostate cancer: an in-depth post hoc analysis of EQ-5D data from the PREVAIL trial

Overview of attention for article published in Health and Quality of Life Outcomes, June 2017

Altmetric Badge

Mentioned by

twitter: 1 tweeter
facebook: 1 Facebook page

reddit: 1 Redditor

Citations

dimensions_citation: 21 Dimensions

Readers on

mendeley: 117 Mendeley

Summary Twitter Facebook Reddit Dimensions citations

So far, Dimensions has found 21 publications that cite this research output.

21

The most recent citing publications are shown below. View all 21 publications that cite this research output on Dimensions.

Patient-reported Outcomes in Men with Metastatic Castration-resistant Prostate Cancer Harboring DNA Damage Response Alterations Treated with Talazoparib: Results from TALAPRO-1

Article in European Urology (June 2022)

Longitudinal study of patients’ health-related quality of life using EQ-5D-3L in 11 Swedish National Quality Registers

Article in BMJ Open (January 2022)

Assessment of Health-Related Quality of Life in Patients with Advanced Prostate Cancer—Current State and Future Perspectives

Article in Cancers (December 2021)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.